Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Casdin Capital, LLC. Officer active across 2 companies, notably GeneDx Holdings Corp.. Cumulatively, 13 filings have been logged. Split: 9 buys · 1 sell. Total volume traded: €67.4m. History available since 4 March 2024. The latest transaction was disclosed on 4 June 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Casdin Capital, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
40,000 shares@ US$8.74271.9% of flowClass A Common StockSEC:0000919574-24-001889:0
Canonical exit: 2 Jun 2024 (T+90)
13 of 13 declarations
About Casdin Capital, LLC
Casdin Capital, LLC is a declarant linked to 13 filings in total. Among the 13 sampled recent filings between 2024-03-06 and 2026-06-08, the reported amounts are EUR 15325043 of buys and EUR 52055174 of sells, with transactions involving GeneDx Holdings Corp. and 2seventy bio, Inc., and the modal transaction nature is Acquisition. It is listed as Director at GeneDx Holdings Corp. and at 2seventy bio, Inc.